- Home
- TOPP vs DYAI Comparison
TOPP vs DYAI Comparison
Compare TOPP & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOPP
- DYAI
- Stock Information
- Founded
- TOPP 2014
- DYAI 1979
- Country
- TOPP United States
- DYAI United States
- Employees
- TOPP N/A
- DYAI 6
- Industry
- TOPP
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TOPP
- DYAI Health Care
- Exchange
- TOPP NYSE
- DYAI Nasdaq
- Market Cap
- TOPP 26.6M
- DYAI 28.3M
- IPO Year
- TOPP 2025
- DYAI 2004
- Fundamental
- Price
- TOPP $1.75
- DYAI $0.98
- Analyst Decision
- TOPP
- DYAI Strong Buy
- Analyst Count
- TOPP 0
- DYAI 1
- Target Price
- TOPP N/A
- DYAI $6.00
- AVG Volume (30 Days)
- TOPP 7.7K
- DYAI 61.9K
- Earning Date
- TOPP 08-11-2025
- DYAI 08-12-2025
- Dividend Yield
- TOPP N/A
- DYAI N/A
- EPS Growth
- TOPP N/A
- DYAI N/A
- EPS
- TOPP N/A
- DYAI N/A
- Revenue
- TOPP $16,117,227.00
- DYAI $3,554,344.00
- Revenue This Year
- TOPP N/A
- DYAI $22.56
- Revenue Next Year
- TOPP N/A
- DYAI $30.95
- P/E Ratio
- TOPP N/A
- DYAI N/A
- Revenue Growth
- TOPP 0.44
- DYAI 57.59
- 52 Week Low
- TOPP $0.97
- DYAI $0.91
- 52 Week High
- TOPP $4.50
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- TOPP N/A
- DYAI 53.08
- Support Level
- TOPP N/A
- DYAI $0.91
- Resistance Level
- TOPP N/A
- DYAI $0.99
- Average True Range (ATR)
- TOPP 0.00
- DYAI 0.06
- MACD
- TOPP 0.00
- DYAI 0.01
- Stochastic Oscillator
- TOPP 0.00
- DYAI 59.93
About TOPP TOPPOINT HOLDINGS INC
Toppoint Holdings Inc is a truckload services and solutions provider focused on the recycling export supply chain. The company operates in one operating segment where it derives its revenues from the delivery of truckload services.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.